Thegrio Politics
@thegriopolitics·150K subscribers·8.3K videos
Pfizer & Moderna Outperform Johnson & Johnson Against Delta Variant, Study Finds
Posted
July 22, 2021
Views
796
Likes
29
Comments
20
Engagement
July 22, 2021
796
29
20
6.16%
Every word spoken in this episode is indexed. Type any phrase to jump straight to the moment it was said.
Type any word or phrase that may have been spoken. Click a result to seek the player to that exact moment.
Try a name, a topic, or a quoted line
11:19Now PlayingThere is a new study about the COVID-19 vaccine that came from a university in New York.
Researchers took antibody titers from multiple people and compared them against the available vaccines. They found that the Johnson & Johnson vaccine was only 30% effective against the Delta variant after one dose and 60% after two doses.
Dr. Kevin Sneed from the University of South Florida Taneja College of Pharmacy joins Laverne McGee to talk about the study.
To watch BNC programming, visit
Follow BNC on social media:
#COVID19Vaccine #DeltaVariant #JohnsonandJohnson
Sentinel Indexing in Progress
Metadata and chapters are available. Claim extraction for this episode is pending.
All video content is delivered via YouTube embedded players in accordance with the YouTube Terms of Service. Sentinel provides research tools that promote discovery and accountability across political media.
